Retatrutide Triple Agonist: Mechanisms, Data, and Fat Loss Potential Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon pathways, offering a novel approach to weight reduction and metabolic optimization. This video examines its pharmacological profile, compares it with Semaglutide and Tirzepatide, and analyzes clinical trial data demonstrating weight loss outcomes of up to 24%. We also discuss dosing protocols, titration considerations, body composition effects, muscle retention strategies, and key metabolic markers including A1C and insulin sensitivity. Subscribe for evidence-based deep dives into metabolic health and performance. https://www.youtube.com/watch?v=RQ1li08ztBg